AIM2 and systemic lupus erythematosus: Additionally, we found higher expression of AIM2‐TFH in SLE patients and further confirmed that CD4+ T cell‐Aim2 accelerates lupus symptoms mediated by regulation of TFH cell differentiation in disease models.